Rebecca Ronsley, MD, FRCPC, is a pediatric neuro-oncologist at Seattle Children’s Hospital, Principal Investigator at Ben Towne Center for Childhood Cancer Research and Assistant Professor of Pediatrics at the University of Washington School of Medicine. Her research program focuses on rapid translation of preclinical work to early phase clinical trials for diffuse midline glioma (DMG) and diffuse intrinsic pontine glioma (DIPG). She is the Study Chair and Principal Investigator for the CNS CAR T trials at Seattle Children’s Hospital and currently leads the open trials BrainChild03 (B7H3 target) and 04 (quad target: B7H3, EGFR, HER2 and IL13ra2).  She also leads and contributes to clinical trials within the PNOC, CONNECT and Children’s Oncology Group Consortia.  She is passionate about bringing access to clinical trials and novel therapeutics to all children and families who are affected by high grade CNS tumors.